IRIDEX CORP
IRIXNasdaqHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY24 | FY23 | FY22 | FY21 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $52.7M | $48.7M | $51.9M | $53.9M | $36.3M | $43.4M |
| Operating income | −$2.6M | −$8.3M | −$10.0M | −$7.5M | −$6.6M | −$9.0M |
| Net income | −$4.4M | −$8.9M | −$9.6M | −$5.2M | −$6.3M | −$8.8M |
| Total assets | $29.2M | $29.1M | $34.4M | $48.7M | $28.0M | $34.8M |
| Total liabilities | $24.2M | $27.0M | $24.9M | $25.4M | $10.6M | $12.1M |
| Equity | $4.9M | $2.1M | $9.5M | $23.3M | $17.4M | $22.7M |
| EPS (diluted) | $-0.26 | $-0.54 | $-0.59 | $-0.34 | $-0.46 | $-0.64 |
| Shares out. | 17.3M | 16.3M | 16.0M | 15.9M | 15.5M | 13.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- −4.9%
- Net margin
- −8.4%
- Return on equity
- −90.1%
- Return on assets
- −15.2%
- Return on capital (ROCE)
- −16.1%
- Liabilities / assets
- 83.1%
- Debt / equity
- 4.92×
- Book value / share
- $0.28
- Revenue growth (YoY)
- 8.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- -8.01distress
- Accruals / assets
- −8.0%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 28, 2008
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2007
- NT 10-Qmissed a reporting deadline ↗May 16, 2007
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Novel Inspiration International Co., Ltd.Activist (13D)Jan 8, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 28,508 | 1.0 | -49.5% |
| Apr 30, 2026 | 56,463 | 1.0 | -46.0% |
| Apr 15, 2026 | 104,611 | 1.0 | +222.1% |
| Mar 31, 2026 | 32,477 | 1.0 | -31.5% |
| Mar 13, 2026 | 47,428 | 1.8 | +3.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 19, 2026
- Results of operationsMar 26, 2026
- Entered a material agreement · New financial obligationMar 13, 2026
- Results of operationsJan 12, 2026
- Regulation FD disclosureDec 11, 2025
- Results of operationsNov 12, 2025
- Other material eventSep 9, 2025
- Results of operationsAug 12, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.